Sacyr S.A. buy krebskrebs
Start price
17.05.20
/
50%
€1.55
Target price
04.11.21
€1.92
Performance (%)
45.99%
End price
05.11.21
€2.27
Summary
This prediction ended on 05.11.21 with a price of €2.27. The BUY prediction by krebskrebs for Sacyr S.A. saw massive gains of 45.99%. Dividends of €0.066 are taken into consideration when calculating the performance. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Sacyr S.A. | 1.440% | 1.440% | 32.247% | 57.670% |
| iShares Core DAX® | 0,85 % | 0,39 % | 2,53 % | 52,00 % |
| iShares Nasdaq 100 | -0,99 % | -4,40 % | 25,15 % | 77,54 % |
| iShares Nikkei 225® | -1,78 % | -11,22 % | 44,40 % | 64,68 % |
| iShares S&P 500 | 0,06 % | 0,78 % | 20,95 % | 63,01 % |
Comments by krebskrebs for this prediction
In the thread Sacyr S.A. diskutieren
In the thread Trading Sacyr S.A.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten